Check out your Company Bowl for anonymous work chats.
We’re heading to #DPharm2025! Join us September 16-17 at the Loews Hotel in Philadelphia, PA, where we’ll showcase how Syneos Health is redefining clinical trial delivery. From reducing patient and site burden to expanding access and representation, our team is driving innovative models that make trials more efficient and inclusive. Book a meeting with us today: go.syneoshealth.com/l/63102/2025-05-16/4tk7hk Stay tuned as we share more about our thought leadership and activities at #DPharm2025 as the event approaches. #SyneosHealth #ClinicalTrials #PatientCentricity #AccessAndInclusion #Innovation
In this episode, host Dr. Wael Harb is joined by biostatistics expert X.Q Xue, PhD, Vice President and Global Head, Biostatistics at Syneos Health to explore how statistical science is transforming dose optimization in oncology drug development. Together, they examine how smaller biotech companies can overcome barriers to implementation, the role of simulation and AI in trial planning and how a biostatistics-driven approach may increase the likelihood of late-phase success, reduce post-marketing adjustments and support faster regulatory approvals. Listen to the full episode: Syneos Health Podcast | Project Optimus Series #SyneosHealth #SyneosHealthPodcast #ProjectOptimus #Biostatistics #DoseOptimization
What’s happening in ophthalmology is bigger than eye care — it’s a glimpse into the future of healthcare, and it is everyone’s business. In this week’s Syneos Health Weekly Sync, we’re diving into how ophthalmology is shaping smarter clinical development, driving new standards in rare disease and genetic medicine and reminding us why the work we do matters. Through segments like Ask an Expert, Spotlight, Watch This, Trending Now and Pulse Check, we’re sharing insights you can use — whether you’re a sponsor, clinician, patient advocate or simply someone who cares about how science changes lives. Read the latest edition to see why this work could matter to someone in your life. Learn more: https://www.syneoshealth.com/therapeutic-depth/ophthalmology #Ophthalmology #ClinicalDevelopment #RareDisease #GeneticMedicine #SyneosHealth #ClinicalTrials #PatientDriven
Syneos Health is attending the Veeva R&D and Quality Summit Europe, June 4–5 in Madrid. Find us at Booth G7 or at the conversations we’re participating in on how smarter systems, stronger partnerships and real-time insights can transforming clinical development. Catch our team in action: Phoebe Benson, Implementation Manager, Syneos Health Consulting, will join the Novo Nordisk team on June 4, to discuss the company’s transformational channels during their first year of the Veeva Clinical data journey, strategy for the redesign process and plans for the next phase of value. Sandrine Yeates Yeates, Sr. Director, Clinical Programming, Biometrics Technical Services, Syneos Health, will speak at the Veeva EDC/CDB Community Meeting on June 5, sharing best practices on feature adoption and release management. Let’s connect in Madrid and explore how we can work together to deliver faster, more connected trials. Book a meeting today: https://lnkd.in/ex_HSKA6
#DIA2025 attendees — ready to think bigger, move faster and deliver differently in an ever-evolving environment? Syneos Health experts will be on the ground sharing insights to help you get ahead of what’s next — from scaling AI to business agility in a global environment. Join us at one of our speaking sessions or book time to connect with us at Booth #1312: DIA Global Annual Meeting 2025 #SyneosHealth #DIA2025
#SyneosHealth is excited to invite you to our upcoming virtual panel discussion: Advancing Your Career as a CRA at Syneos Health. Join us on Thursday, May 15, 2025, at 4 p.m. (Argentina time) and discover how Syneos Health can help take your career to the next level. Hear from industry experts as they share their experiences and learn how you can become part of an innovative and growing team. Featuring speakers: • Karina De Lazzari – Senior Vice President, FSP 360 • Michelle Ballantyne – Director, Clinical Operations • Alejandra Ramos – Associate Director, Clinical Operations • Fernanda Pereiro – Associate Director, Clinical Operations • Diego Carri – Clinical Operations Manager Take this opportunity to learn, connect, and explore how you can grow professionally with Syneos Health. Register now: https://event.on24.com/wcc/r/4947689/1D159180B5DB6B16D7349CF12AC6F2C9 #SyneosHealthLife #WorkHereMattersEverywhere #CRA #HealthcareCareers
What’s next for AI and disruptive tech in clinical development? Join Syneos Health’s Ben Phillips, PhD, at BioKorea on Friday, May 9 for a forward-looking session: “What to Look Out For: Trends in AI and Disruptive Tech in Clinical Development.” Details here: BIO KOREA 2025 Explore the innovations shaping 2025 and beyond—and gain insights to stay ahead in an evolving landscape. #BioKorea #AIinHealthcare #ClinicalDevelopment #SyneosHealth #DigitalHealth #Biotech
SyneosHealth is one of the industry leaders in the design and conduct of ophthalmology clinical trials. By leveraging our global scale, therapeutically experienced study teams and long-standing site relationships, we are well positioned to help customers of all sizes thoughtfully advance their ophthalmology therapies through clinical development and commercial launch. Explore how our ophthalmology expertise drives results: https://www.syneoshealth.com/therapeutic-depth/ophthalmology Ophthalmology Contract Research Organization | Syneos Health
🌍 Today we celebrate Earth Day — a reminder that progress and purpose go hand in hand. At Syneos Health, sustainability is more than a value — it’s a responsibility. #EarthDay2025 #SyneosHealth #PlanetAndPeople #WorkHereMattersEverywhere #SustainableFuture
On #MultipleMyelomaAwarenessMonth, we’re spotlighting the science changing the story. Dr. Liat Vidal shares a frontline view of how bispecific antibodies are reshaping clinical trials and expanding hope for patients with multiple myeloma. Connect with our experts to explore how your next multiple myeloma trial can leverage bispecifics antibodies effectively: https://www.syneoshealth.com/therapeutic-depth/oncology-and-hematology
